Cancers are the most heterogenous group of diseases affecting humans. Multiple compensating pathways work to promote disease progression. Various immunotherapies have shown anti-cancer promise, but  their targeted nature limits the scope of their action and applicability.

In this webinar, a panel of experts, including Dr. Bruce Levine, Barbara and Edward Netter Professor in Cancer Gene Therapy at University of Pennsylvania, come together to discuss their research and share insights into the potential these therapeutics hold in the fight against various tumor types.

Watch this webinar to learn more about:

• Molecular mechanisms of PD-L1 regulation in cancer cells
• The immunosuppressive nature of triple negative breast cancer
• Using in vitro co-culture system to analyze T cell-mediated cancer cell killing effect